These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 11803072)
21. Modelling the impact of varicella vaccination on varicella and zoster. Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447 [TBL] [Abstract][Full Text] [Related]
22. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination. Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890 [TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Hoshi SL; Kondo M; Okubo I Vaccine; 2017 May; 35(24):3264-3271. PubMed ID: 28479176 [TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. Wolfson LJ; Daniels VJ; Pillsbury M; Kurugöl Z; Yardimci C; Kyle J; Dinleyici EC PLoS One; 2019; 14(8):e0220921. PubMed ID: 31408505 [TBL] [Abstract][Full Text] [Related]
25. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Schuette MC; Hethcote HW Bull Math Biol; 1999 Nov; 61(6):1031-64. PubMed ID: 17879870 [TBL] [Abstract][Full Text] [Related]
26. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Carville KS; Riddell MA; Kelly HA Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265 [TBL] [Abstract][Full Text] [Related]
27. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence. Harpaz R; van Hoek AJ J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602 [TBL] [Abstract][Full Text] [Related]
28. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix. Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457 [TBL] [Abstract][Full Text] [Related]
29. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Kelly HA; Grant KA; Gidding H; Carville KS Euro Surveill; 2014 Oct; 19(41):. PubMed ID: 25345520 [TBL] [Abstract][Full Text] [Related]
30. Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Goldman GS; King PG Vaccine; 2013 Mar; 31(13):1680-94. PubMed ID: 22659447 [TBL] [Abstract][Full Text] [Related]
31. The cost-effectiveness of routine childhood varicella vaccination in Germany. Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807 [TBL] [Abstract][Full Text] [Related]
32. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil. Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917 [TBL] [Abstract][Full Text] [Related]
33. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. Brisson M; Edmunds WJ; Gay NJ J Med Virol; 2003; 70 Suppl 1():S31-7. PubMed ID: 12627484 [TBL] [Abstract][Full Text] [Related]
34. Clinical and economic considerations of vaccination against varicella. Strassels SA; Sullivan SD Pharmacotherapy; 1997; 17(1):133-9. PubMed ID: 9017774 [TBL] [Abstract][Full Text] [Related]
35. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754 [TBL] [Abstract][Full Text] [Related]
36. Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives. Hsu HC; Lin RS; Tung TH; Chen TH Vaccine; 2003 Sep; 21(25-26):3982-7. PubMed ID: 12922134 [TBL] [Abstract][Full Text] [Related]
37. [Varicella vaccination: scientific reasons for a different strategic approach]. Donzelli A; Demicheli V Epidemiol Prev; 2018; 42(1):65-70. PubMed ID: 29506363 [TBL] [Abstract][Full Text] [Related]
38. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Chao DY; Chien YZ; Yeh YP; Hsu PS; Lian IB Epidemiol Infect; 2012 Jun; 140(6):1131-40. PubMed ID: 21906410 [TBL] [Abstract][Full Text] [Related]
39. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Gao Z; Gidding HF; Wood JG; MacIntyre CR Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116 [TBL] [Abstract][Full Text] [Related]
40. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]